The development of appropriate statistical methodologies for neuroimaging studies is dependent upon the research question of interest. Often studies are analyzed with techniques that may not be appropriate for the research question but are accepted owing to conven tion, familiarity, or apparent statistical sophistication. Neuroimaging data are particularly complex owing to (a) the high number of potential dependent variables (i.e., regions of interest) coupled with the practical limitations on sample size ; (b) the known physical properties of scan ners (e.g., resolution) interacting with the intricate and variable structure of the human brain; and (c) mathemat ical properties introduced into the data by the physiolog ical model for quantification. In this article, a statistical
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The development of appropriate statistical methodologies for neuroimaging studies is dependent upon the research question of interest. Often studies are analyzed with techniques that may not be appropriate for the research question but are accepted owing to conven tion, familiarity, or apparent statistical sophistication. Neuroimaging data are particularly complex owing to (a) the high number of potential dependent variables (i.e., regions of interest) coupled with the practical limitations on sample size ; (b) the known physical properties of scan ners (e.g., resolution) interacting with the intricate and variable structure of the human brain; and (c) mathemat ical properties introduced into the data by the physiolog ical model for quantification. In this article, a statistical It is clearly established that the measurements of regional CMRgl c (rCMRgl c) using the e S F]-fluoro deoxyglucose (FDG) tracer analogue and positron emission tomography (PET) are sensitive to meta bolic decreases in rCMRgl c in individuals with neu rodegenerative disease such as symptomatic Hun tington's disease (HD) or Alzheimer's disease (Chase et aI., 1984; Hayden et aI., 1986; Mazziotta et aI., 1987) . However, the ability to identify subtle metabolic changes before clinical onset may be crit ical to the development of effective treatment strat egies. Specifically, by the time symptoms appear clinically, the disease process may have advanced to a point where neuronal death is too extensive for successful intervention. The purpose of the current article is to describe a statistical method for deter-mining the likelihood or probability of an asymp tomatic individual having metabolic changes that are consistent with a specific disease process.
The subjects consisted of 26 normal controls, 32 patients with symptomatic HD, and 28 persons at risk for HD. HD was thought to be an ideal disease to test this approach because (a) previous FDG/ PET studies have shown marked decreases in the absolute rate of caudate metabolism; (b) based on family history, at-risk individuals can be identified easily; (c) typically, one can expect 50% of the at risk individuals to develop the disease; and (d) there is considerable variation among individuals in terms of the age at onset. The latter two points suggest that the at-risk subjects cannot be considered a ho mogeneous group in terms of change of caudate me tabolism because only 50% will have these changes and the changes may or may not predate clinical manifestation of the disease.
In developing a probabilistic model, there are a number of potential confounds that must be con trolled, such as age and possible individual varia tions in the lumped and rate constants. In addition, STATISTICAL METHODOLOGY FOR FDG/PET A97 there are a number of sources of error that must be minimized, such as head position and variation de rived from the data extraction technique. Besides these methodological and experimental concerns, there are empirical criteria that must be met, namely, sensitivity and specificity with high levels of confidence for the individual case. Unlike group statistics where a positive finding may be replicated even though individual rates of rCMRgl c may vary considerably over time, one must be assured in a probabilistic model that a similar or consistent find ing would be found on reexamination for each indi vidual.
The approach presented here is a four-stage model. The first step was to determine the most accurate set of cortical and thalamic estimates of rCMRg l c for predicting caudate metabolism in nor mal subjects. By using absolute metabolic rates in the prediction equation, one controls f or individual differences in the lumped and rate constants as well as potential normal aging effects. The second step was to apply these prediction equations to region of-interest (ROI) data derived from a set of con firmed HD patients. From this analysis, the residu als or the num b er of metabolic units that the pre dicted caudate rates differed from obtained values could be calculated. The third stage was to submit the left and right residuals to a linear discriminant function analysis to determine how well these re siduals separated normal subjects from HD pa tients. The final step was to apply these equations to a set of at-risk patients to determine the proba bility of these subjects being either normal or ab normal in terms of caudate metabolism. As some of these at-risk subjects had been scanned twice, it was also possible to determine the variation over time in the estimated probabilities.
METHODS

Subjects
The sample consisted of 26 normal controls, 32 patients with symptomatic HD, and 28 persons at risk for HD of whom 8 were scanned at least twice. The diagnosis of HD was based on a positive family history and documented neurologic/psychiatric signs and symptoms consistent with HD. For the purpose of analysis, the HD subjects were subdivided into early (symptomatic for ",, 5 years; n = 19) and late (symptomatic for >5 years; n = 13). The at-risk patients (AR) were individuals who had a positive family history but were asymptomatic at the time of the initial scan. These persons had no chorea and no distur bances in voluntary movements as assessed by clinical examination. The groups did not differ in mean age (F = 1.10, p "" 0 . 3; Xnormal = 44 .8, XHD = 45 .1, XAR = 3 9 .5) or age range (20-81 years for the normals, 18-77 years for HD subjects, and 27-76 years for at-risk subjects).
PET procedures
PET was performed with the UBC PETT VI imaging system. This system consists of an instrument with four rings of detectors that allows data to be recorded simul taneously from seven transverse sections, each -11 mm in thickness. All studies were done in the high-resolution mode, giving an average in-plane (i.e., transverse) reso lution of 9.2 mm full width at half-maximum (Evans et al., 1983) .
Patient preparation included the percutaneous insertion of a radial artery catheter under local anesthesia to permit frequent sampling of arterial blood and the insertion of an intravenous catheter for isotope injection in the opposite arm. The head was positioned with the aid of a vertical laser line so that the center of the lowest slice corre sponded to the patient's orbitomeatal line. A molded plas tic facemask prevented major head movements during the scan. After the head was in place, a transmission scan was performed with a ring phantom containing 68 Ge for attenuation correction. A second transmission scan was performed after shifting the patient position by 7 mm in the z-axis (i.e., half of one slice thickness). These data permitted proper corrections for photon attenuation to be applied to emission data acquired in each of these two positions. During the emission scans, the room was dark ened and the patient's eyes were covered. The ears were not occluded. Ambient room noise during the scans con sisted almost entirely of low-frequency noise emanating from the wobble mechanism of the tomograph gantry.
For the measurement of rCMR g l c , an emission scan (scan length 15 min) was performed starting 40 min after an intravenous injection of 3-5 mCi of FDG. A second IS-min emission scan was then performed after shifting the patient's position 7 mm in the z-axis (half of one slice thickness). The resultant data set consisted of interleaved transverse sections, each 1 4 mm thick, with a center to-center spacing of 7 mm. Sequentially timed arterial blood samples were drawn starting at the time of injection and continuing until the end of the second emission scan. Plasma aliquots were counted in a well counter to obtain the activity of 18 F in each sample, and this activity was corrected for physical decay to the time of injection. Scan data were similarly corrected for 18 F decay. Calibration of the tomograph to obtain the actual regional isotope concentration in the brain from the reconstructed image was performed by imaging a homogeneous phantom filled with a known concentration of 18 F. Plasma glucose was measured before FDG administration and at intervals during the scanning procedure. rCMR g lc was calculated from the emission scan and blood curve data by using the model of Sokoloff et al. (1977) as later modified by Huang et al. (1980) . Brooks's method of calculation (1982) was adopted (Sokoloff et aI., 1977; Huang et aI., 1980) . The lumped constant was taken as 0.418, and literature values for gray matter rate con stants were used (Huang et al., 1980) .
Data extraction
Twenty-one estimates of cortical metabolism as well as left and right cerebellar estimates were obtained using a set of standard or reference slices. For each subject, five slices were selected that best conformed to those shown in Fig. 1 . Circular or elliptical ROIs with equivalent areas (1.2 cm 2 ) were placed such that their position corre sponded to the ROIs on Fig. 1 and the regional metabolic rates were maximized. Metabolic estimates for the right and left thalamus and head of the caudate were taken from the two slices where these structures were best vi sualized. The highest of the two estimates for each region was then selected for subsequent analysis. The two slices and ROI placements are shown in Fig. 2 . These proce dures partially control for individual differences in head placement and angulation and have been shown to have high interrater reliability (Clark, 1987) .
ANALYSIS OF RESULTS
The first step in the procedure was to identify in the normal sample a set of ROls that accurately predicted the rCMRg \ c of the right and left caudates in the normal samples. Therefore, two stepwise multiple regression analyses (i.e., one for each cau date) were done using the 25 regions as predictors. For the right caudate, three predictors (F to enter, p � 0.05; F to remove, p?c 0.10) were identified that accounted for 92% of the variability in the right cau date values. These predictors were the right and left frontal cortex of slice 2 as shown in Fig. I and the right thalamus. For the left caudate, two predictors, the right frontal cortex of slice 2 and the right thal amus, were selected and accounted for 83% of the variability in the left caudate values. The F values and mUltiple correlation coefficients (r) for these analyses are presented in Table 1 . These findings indicate that in normal individuals, caudate metab olism may be very accurately predicted based on the rCMR I rates of other ROIs. Given the reported gc magnitudes of interregional correlations of absolute metabolic rates by others, these findings are not unexpected (Horwitz, 1984) . It should be noted that the selection of predictors in this analysis was based solely on the statistical criteria of maximizing pre diction with smallest number of predictors. If one wished, predictors could be selected and tested based on clinical criteria such as areas not typically involved in the disease process.
The next step of the analysis was to determine whether such accurate predictions would be found for the HD patients or whether caudate metabolism would be overestimated by these prediction equa tions owing to the disease process in HD. There fore, the regression equations derived above were applied to the rCMRgl c of the previously identified ROIs for the HD patients. The dependent measure in this portion of the procedure was the residual or the actual metabolic rate of the caudate minus the predicted value. Although these residuals are rela tive measures, their units are still metabolic rates (mg/min/IOO g tissue). Therefore, the specific ques tion being asked is: Given the rates of cortical and thalamic metabolism, is the actual caudate rate lower or higher than one would expect, and by how many metabolic units? The results of this analysis are summarized in Table 2 . As a least-squares fit was applied to the normal data, their mean residual is 0.00. For the rCMRgl c of both caudates, the actual rates for the HD group were significantly lower than their predicted scores, suggesting reductions in cau date metabolism relative to the rCMRgl c of other regions. This finding is consistent with previous re ports in HD (Mazziotta et aI., 1985; Clark et aI., 1986; Hayden et aI., 1986; Young et aI., 1987) . The third step in the procedure was to determine the best weighting of caudate residual rates to max imize the separation between the normal and HD groups and then to determine the accuracy of this weighting in terms of classification. Therefore, the residual rates for the right and left caudates were used as predictors of group membership (i.e., nor mal, HD < 5 years, HD > 5 years) in a linear dis criminant function analysis. The classification table of HD versus normal is presented in Table 3 . The overall rate of classification was 98.3% with all the normals being correctly classified and one HD pa tient being incorrectly classed as normal. This anal ysis calculates a discriminant score for each sub ject, and this score is used to determine the proba bility of each person being a member of each group, assuming equal probability of being HD or normal. These probabilities for each subject are given in Ta ble 4 for the normal subjects and Table 5 for the HD patients. For the normal group, the probability of being normal was <0.7 in only one case (case 12; Table 4 ), while for the HD groups, the probability of being normal was >0.3 in only three cases. These data reaffirm the group comparisons for the individ ual cases and indicate very good separation be tween the groups.
The last two steps of the procedure were to gen erate discriminant scores and their related probabil ities for the at-risk subjects and to determine the stability of these estimates in the eight at-risk pa tients who had been scanned more than once. For the 28 at-risk subjects, 21 had discriminant scores in the normal range [p(norm) > 0.6], 6 in the HD range As the object of the analysis was to obtain estimates ? f tru � / false positives/negatives, the two HD groups are combmed m this table. Specifically, the probability of HD (p HD '" 5-.1' r d � ration + HD > 5-yr duration) was calculated for each subject; If p(HD) > 0.5, then the subject was classified as HD. . From a clinical standpoint, re scanning in the near future would be advised for these subjects. These data are given in Table 6 . With respect to the stability of these probabilities, five of the "normal" at-risk subjects and three of the "HD" at-risk subjects have been rescanned. These data are provided in Table 7 . For four of five "normal" at-risk predictions, there was virtually no change in the probability estimates. The fifth sub ject was normal but did exhibit a marginal drop in the normal probability estimate (from 0.90 to 0.84). For three "HD" at-risk subjects, the second scans were more similar to those of HD than the first, suggesting ongoing decrements in caudate metabo lism. From Table 5 , it is evident that the procedures outlined permit a probability statement to be made with respect to the likelihood of the metabolic changes associated with HD being present. More over, the data on eight at-risk subjects who were rescanned suggest that these estimates are very re liable.
DISCUSSION
These findings clearly indicate that the proposed statistical model can provide accurate and reliable probabilistic statements of the likelihood of an in dividual PET scan being normal or similar to those of HD patients. Before discussing the implications of these findings, it is important to note that the FDG/PET data in this study do not differ markedly from those reported in the literature. However, the statistical approach was designed (a) to capitalize on the known properties of rCMRgl c in normal sub jects and the reported differences between normal subjects and HD patients (Mazziotta et ai., 1985; Clark et ai., 1986; Hayden et ai., 1986; Young et ai., 1987) and (b) to minimize the artifact introduced by ratio measures (e.g., caudate to whole slice) and perhaps data extraction tech niques. Specifically, in normal subjects high inter regional correlations of absolute rates are typically reported. For example, Clark et al. (1985) found that for the ECAT-II system, 74.8% of metabolic variability between subjects was accounted for by individual differences in absolute rate of metabo lism. There is a growing PET literature on statistical methods for removing this variability in the analysis of data (Horwitz et ai., 1984; Moeller et ai., 1987) . In contrast, the regression approach in the current study capitalized on this fact to generate accurate prediction of caudate metabolism for the normal made regarding the rate of hypometabolism. By us ing this approach, the confounding of interregional coupling and actual metabolic rates introduced when one uses ratio measures is also avoided. The method of data extraction has been shown to be reliable in previous studies, but unlike many auto mated procedures permits visual interaction with the image. This property allows for accommodation to individual variations in brain size, shape, and placement within the scanner. Another inherent problem in the study of individuals at risk for HD is the sampling of the at-risk population. Specifically, all PET centers report that metabolic reductions in the caudate are associated with clinical onset of this disease (Mazziotta et aI., 1985; Hayden et aI., 1986; Young et aI., 1987) . There is, however, a debate over whether the reduction predates clinical mani festation (Hayden et aI., 1986; Mazziotta et aI., 1987; Young et aI., 1987) . From these reports and the probability of inheriting the gene, it is clear that in any study of at-risk subjects, the majority will have normal caudate metabolism (i.e., only those in whom the disease process has progressed suffi ciently will exhibit reduced caudate metabolism). As a result of the ability to analyze metabolic pat terns individually, these subjects will be identified regardless of whether they constitute 1-100% of the sample. Given this background, we suggest that the results reported here would be replicated if similar experimental procedures and the outlined model were applied to the HD data of other PET centers.
The strength of the proposed model is based on the almost perfect discrimination between the HD patients and the normal controls (98.3%). The one HD patient who was misclassified was on neurolep tic medication at the time of the scan. De Lisi et ai. (1985) suggests that such medication may increase the metabolic rate of the basal ganglia structures. It should be noted also that for two of the HD pa tients, their combined HD probabilities were only 53 and 51% (subjects 5 and 18). These findings sug gest that idiosyncratic factors such as medication regimen at the time of scan may produce false neg atives. These factors must be controlled for and ex plored further to ensure that potential false nega tives do not occur.
With respect to external validation in terms of symptom manifestation, two of the at-risk subjects with a scan similar to that for HD developed very early signs of HD by the time of their second scan �2 years later. For the two with early signs (sub jects 23 and 26 in Tables 6 and 7) , their HD proba bilities were 0.69 and 0.90 on the first scan and 0.90 and 0.94 on the second. Of particular interest is the fact that the positive PET scans predated manifest clinical signs on a neurological examination by at least 2 years. In a third subject with soft signs on a second examination manifest by mild incoordina tion when performing complex alternating move ments of the hands (subject 25 in Tables 6 and 7) , the HD probabilities were 0.80 on the first scan and 0.86 on the second. Again, there was a 2-year pe riod between the scans and the physical examina tions. These observations support the hypothesis that metabolic changes occur close to but may pre date symptom onset.
In conclusion, this statistical approach clearly needs to be further validated in the case of HD. However, the initial findings are encouraging. The strengths of the approach within a statistical frame work include (a) the avoidance of potential arithme tic artifact introduced by standardization. (b) the ability to classify subjects where one does expect a consistent change, (c) exploiting the known interre gional relationships to make accurate predictions. and (d) the generation of a probabilistic statement of the likelihood of an individual scan being normal or abnormal. Besides maximizing statistical discrimi nation and sensitivity, the model is conceptually consistent with our knowledge of cerebral glucose metabolism in humans.
